PHK
ALXO icon

Point72 Hong Kong’s ALX Oncology ALXO Stock Holding History

Point72 Hong Kong’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-916
Closed -$9K – 116
2022
Q3 		$9K Sell
916
-1,167
-56% -$13.6K ﹤0.01% 1729
2022
Q2 		$17K Sell
2,083
-1,798
-46% -$19.6K ﹤0.01% 1590
2022
Q1 		$66K Sell
3,881
-1,743
-31% -$29.8K ﹤0.01% 1268
2021
Q4 		$121K Buy
+5,624
New +$243K ﹤0.01% 1135

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Hong Kong's ALXO Position: Q4 2022 in Review

Point72 Hong Kong sold out of ALX Oncology (ALXO) in Q4 2022, closing a stake of 916 shares — an estimated $9K sold.

Point72 Hong Kong first reported a position in ALXO in Q4 2021 and held it in 4 quarters. The position peaked at $121K in Q4 2021. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2022.

  • Point72 Hong Kong reported no remaining ALX Oncology position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 916 ALX Oncology shares in Q4 2022, an estimated $9K.
  • Point72 Hong Kong first reported a position in ALX Oncology in Q4 2021 and held it in 4 quarters.
  • Point72 Hong Kong's ALX Oncology position peaked at $121K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.